Prestige BioPharma Limited
KSE:950210.KS
15,030 (KRW) • At close October 17, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Prestige BioPharma Limited |
Symbool | 950210.KS |
Munteenheid | KRW |
Prijs | 15,020 |
Beurswaarde | 902,644,248,100 |
Dividendpercentage | 0% |
52-weken bereik | 7,610 - 16,220 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Ms. So-Yeon Park |
Website | https://www.prestigebiopharma.com |
An error occurred while fetching data.
Over Prestige BioPharma Limited
Prestige BioPharma Limited, a biopharmaceutical company, engages in the research, development, and marketing of biosimilars and new antibody therapeutics in the Asia Pacific. The company primarily engages in the development of new and similar antibody drugs for solid tumor, pancreatic cancer, breast cancer, gastric cancer, and arthritis. It is also
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (KRW)
Cijfers zijn in miljoenen (KRW)